AN2 Therapeutics, Inc. announced the appointment of Maggie FitzPatrick to its Board of Directors. Ms. FitzPatrick has served in leadership positions in the public, private and non-profit sectors and brings a breadth of experience in healthcare, climate change and global health. Ms. FitzPatrick is a member of the board of directors at VistaGen Therapeutics.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.015 USD | -1.23% | -0.25% | -90.17% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-90.17% | 59.36M | |
+43.36% | 54.63B | |
-5.31% | 39.92B | |
+14.75% | 26.86B | |
-12.56% | 26.22B | |
-22.45% | 18.78B | |
+25.12% | 12.21B | |
+0.04% | 12.16B | |
+26.04% | 11.94B | |
-11.83% | 10.74B |
- Stock Market
- Equities
- ANTX Stock
- News AN2 Therapeutics, Inc.
- AN2 Therapeutics, Inc. Appoints Maggie Fitzpatrick to its Board of Directors